These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Treatment of Alzheimer's disease with cholinergic drugs. Kumar V; Calache M Int J Clin Pharmacol Ther Toxicol; 1991 Jan; 29(1):23-37. PubMed ID: 2004862 [TBL] [Abstract][Full Text] [Related]
5. [Tacrine against Alzheimer disease? Still uncertain for which patients may the treatment be beneficial]. Wallin A Lakartidningen; 1996 Jan; 93(1-2):22-4. PubMed ID: 8544526 [No Abstract] [Full Text] [Related]
6. Treating Alzheimer's disease with cholinergic drugs, Part I. Terpstra T; Terpstra T Nurse Pract; 1998 Nov; 23(11):90, 92, 97 passim. PubMed ID: 9834506 [No Abstract] [Full Text] [Related]
7. [Cholinergic agents in the treatment of Alzheimer's disease]. Zemishlany Z; Davidson M; Davis KL Harefuah; 1987 Dec; 113(12):401-4. PubMed ID: 3330722 [No Abstract] [Full Text] [Related]
8. The treatment of cognitive impairment in Alzheimer's disease: beyond the cholinergic approach. Davidson M; Stern RG Psychiatr Clin North Am; 1991 Jun; 14(2):461-82. PubMed ID: 2062728 [TBL] [Abstract][Full Text] [Related]
9. [The cholinergic perspectives in the treatment of Alzheimer's disease: tacrine]. Royuela Rico A; Macías Fernández JA Rev Clin Esp; 1995 Jul; 195(7):473-8. PubMed ID: 7667523 [No Abstract] [Full Text] [Related]
10. [The effects of cholinergic preparations in Alzheimer's disease]. Bradley RJ; Edge MT; Freeman AM Farmakol Toksikol; 1991; 54(3):4-10. PubMed ID: 1915820 [No Abstract] [Full Text] [Related]
11. Tacrine. Alzheimer's disease and the cholinergic theory. A critical review and results of a new therapy. Boller F; Orgogozo JM Neurologia; 1995 May; 10(5):194-9. PubMed ID: 7619536 [No Abstract] [Full Text] [Related]
12. [Cholinergic treatment strategies in Alzheimer's disease]. Kurz A; Rüster P; Romero B; Zimmer R Nervenarzt; 1986 Oct; 57(10):558-69. PubMed ID: 3785472 [No Abstract] [Full Text] [Related]
13. A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group. Davis KL; Thal LJ; Gamzu ER; Davis CS; Woolson RF; Gracon SI; Drachman DA; Schneider LS; Whitehouse PJ; Hoover TM N Engl J Med; 1992 Oct; 327(18):1253-9. PubMed ID: 1406817 [TBL] [Abstract][Full Text] [Related]
14. Tacrine for Alzheimer's. Handly M Am Pharm; 1991 Dec; NS31(12):8. PubMed ID: 1763782 [No Abstract] [Full Text] [Related]
15. [Drugs for Alzheimer's disease]. Taurand P Soins; 1995 Mar; (594):61-2. PubMed ID: 7716573 [No Abstract] [Full Text] [Related]
16. Tacrine and lecithin in Alzheimer's disease. Tacrine is safe and effective. Pendlebury WW; Solomon PR BMJ; 1994 Jun; 308(6942):1506; author reply 1507. PubMed ID: 8019290 [No Abstract] [Full Text] [Related]
17. Maximizing function in Alzheimer's disease: what role for tacrine? Smucker WD Am Fam Physician; 1996 Aug; 54(2):645-52. PubMed ID: 8701842 [TBL] [Abstract][Full Text] [Related]
18. Tacrine therapy for the dementia of Alzheimer's disease. Manning FC Am Fam Physician; 1994 Sep; 50(4):819-26. PubMed ID: 8079912 [TBL] [Abstract][Full Text] [Related]
19. [Alzheimer's disease]. Derouesné C Presse Med; 1992 Jan 4-11; 21(1):13-5. PubMed ID: 1531257 [No Abstract] [Full Text] [Related]
20. Do blood pressure and age predict response to tacrine (THA) in Alzheimer's disease? A preliminary report. Schneider LS; Lyness SA; Pawluczyk S; Gleason RP; Sloane RB Psychopharmacol Bull; 1991; 27(3):309-14. PubMed ID: 1775604 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]